ChromaDex’s Pterostilbene Gets GRAS
The company adds that the first human clinical trial to evaluate pTeroPure’s effects in patients with lipid, or cholesterol, disorders is underway at the University of Mississippi.
ChromaDex Corp.’s (Irvine, CA) pTeroPure pterostilbene ingredient has received generally recognized as safe (GRAS) status for potential use in food and beverages.
The ingredient is said to be an ultrapure form of the naturally occurring compound pterostilbene, which is found in blueberries. It has potential for supporting heart health through maintaining healthy cholesterol and blood pressure levels, while also providing additional benefits for cognitive function and healthy aging.
“The industry experts from the American Institute for Biosocial and Medical Research, including former U.S. Department of Agriculture and FDA staffers, all agreed that pTeroPure merits this designation,” stated Frank Jaksch, ChromaDex’s CEO.
The company adds that the first human clinical trial to evaluate pTeroPure’s effects in patients with lipid, or cholesterol, disorders is underway at the University of Mississippi. Primary markers being studied are high- and low-density lipoprotein cholesterol. Secondary endpoints include blood pressure, markers of oxidative stress, and safety.
The ingredient was also named the 2010 North American Most Promising Ingredient of the Year by Frost & Sullivan.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
